Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 25, Amicus Therapeutics, Inc.
Keep Reading →
July 6 - News
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Keep Reading →
July 5 - Hedge Funds, News
Amicus Therapeutics Inc. (NASDAQ:FOLD) is one of the best biotech stocks to invest in now.
Keep Reading →
June 24 - News
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
Keep Reading →
June 24 - News
On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously ...
Keep Reading →
May 12 - Hedge Funds, Industries, News
Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics First Quarter 2025 Financial Results Conference Call and Webcast.
Keep Reading →
May 2 - News, Transcripts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Keep Reading →
April 21 - Hedge Funds, News
Low priced stocks usually fall under the small to mid-cap size category.
Keep Reading →
April 9 - Hedge Funds, News
Markets are wobbling, and panic is becoming the headline. At times when stocks are tumbling, headlines are filled with forecasts that cause anxiety for investors.
Keep Reading →
April 7 - Hedge Funds, News
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
Keep Reading →
March 14 - Hedge Funds, Industries, Lists
Small-cap stocks in the U.S. have suffered as the broader market is under pressure due to the ongoing tariff policy transition.
Keep Reading →
March 10 - Hedge Funds, News
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
Keep Reading →
February 22 - Hedge Funds, Industries, News
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Call Transcript February 19, 2025Amicus Therapeutics, Inc. beats earnings expectations.
Keep Reading →
February 20 - News, Transcripts
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Keep Reading →
January 20 - Hedge Funds, News
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Keep Reading →
January 17 - Hedge Funds, News
The medical industry plays a crucial role in ensuring the health and safety of populations.
Keep Reading →
January 11 - Hedge Funds, Industries, News
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2024 Earnings Call Transcript November 6, 2024Amicus Therapeutics, Inc. beats earnings expectations.
Keep Reading →
November 7 - News, Transcripts
Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the right set of vehicles to either preserve or grow money...
Keep Reading →
September 23 - Hedge Funds, News
Operator: Good morning, ladies and gentlemen. And welcome to the Amicus Therapeutics Second Quarter 2024 Financial Results Conference Call and Webcast.
Keep Reading →
August 10 - News, Transcripts
Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15985 EPS, expectations were $-0.06. Amicus Therapeutics, Inc.
Keep Reading →
May 10 - News, Transcripts
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
Keep Reading →
March 13 - News
Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics' Full Year 2023 Financial Results Conference Call and Webcast.
Keep Reading →
February 29 - News, Transcripts
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this article, we present 15 best growth stocks under $25.
Keep Reading →
January 3 - Hedge Funds, News
Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Third Quarter 2023 Financial Results Conference Call and webcast.
Keep Reading →
November 10 - News, Transcripts
Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Second Quarter 2023 Financial Results Conference Call and webcast.
Keep Reading →
August 10 - News, Transcripts
Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics first quarter 2023 financial results conference call and webcast.
Keep Reading →
May 14 - News, Transcripts
Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics Full Year 2022 financial results conference call and webcast.
Keep Reading →
March 8 - News, Transcripts
In this article, we will take a look at the 12 best 52-week high stocks to buy now.
Keep Reading →
December 28 - Hedge Funds, News
In this article, we will discuss the 10 best medical stocks under $10.
Keep Reading →
August 6 - Hedge Funds, News
In this piece, we will take a look at the top five best stocks to buy under $20 according to Jeremy Green's Redmile Group.
Keep Reading →
May 3 - Hedge Funds, News
In this article, we will discuss the top 10 biotech stocks to buy according to Jeremy Green's Redmile Group.
Keep Reading →
February 17 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
February 7 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 10 - Hedge Funds, News
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Keep Reading →
November 30 - Hedge Funds, News
In this article, we discuss the best small-cap stocks to buy.
Keep Reading →
October 29 - Hedge Funds, News
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Keep Reading →
October 23 - Hedge Funds, News
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
Keep Reading →
October 15 - Hedge Funds, News
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
October 12 - Hedge Funds, News
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Keep Reading →
July 6 - Hedge Funds, News
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be ...
Keep Reading →
May 5 - Hedge Fund Investor Letters, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
April 8 - Hedge Funds, News
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
December 21 - Hedge Funds, News
Below are the 5 best biotech stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Keep Reading →
December 19 - News
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
September 15 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 12 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 8 - Hedge Funds, News
We hate to say this but, we told you so.
Keep Reading →
March 28 - Hedge Funds, News
2018's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about...
Keep Reading →
January 10 - Hedge Funds, News
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Keep Reading →
December 5 - Hedge Funds, News
